Previous 10 | Next 10 |
PATTERSON, N.J. and JERUSALEM, Israel, June 09, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced that it will report its fi...
PATTERSON, N.J., May 20, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced the appointment of Christopher Boyer as Vice Pre...
Hadar Levy Promoted to Senior Vice President and General Manager of North America Company Appoints Seasoned Medical Technology Finance Professional, Judith Huber, as Senior Vice President and Chief Financial Officer PATTERSON, N.J. and JERUSALEM, May 06, 2020 (GLOBE NEWSWIRE) -- Bra...
PATTERSON, N.J., May 04, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders, today announced the launch of #StandAgainstTheS...
BrainsWay (NASDAQ: BWAY ) sees Q1 revenue in the range of $3.9M-$4.2M vs. consensus of $4.97M. More news on: Brainsway Ltd., Healthcare stocks news, Read more ...
PATTERSON, N.J., April 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced a preliminary, unaudited revenue range for the ...
VADNAIS HEIGHTS, Minn., April 07, 2020 (GLOBE NEWSWIRE) -- The Remedy , a person-centered mental health care facility offering advanced treatments, announced today that it is now offering BrainsWay’s Deep Transcranial Magnetic Stimulation (Deep TMS) for major depressive disord...
Quick Take Brainsway ( BWAY ) went public in April 2019, raising $28 million in gross proceeds from an IPO. The firm designs and sells non-invasive medical devices to treat psychological disorders. BWAY continues to produce revenue and gross profit growth and has future growth prospects ...
Brainsway Ltd. (BWAY) Q4 2019 Earnings Conference Call March 23, 2020 08:30 AM ET Company Participants Bob Yedid - LifeSci Advisors Christopher von Jako - CEO Hadar Levy - COO and CFO Conference Call Participants Craig Bijou - Cantor Fitzgerald Jayson Bedford - Raymond Ja...
Brainsway (NASDAQ: BWAY ): Q4 GAAP EPS of -$0.10 beats by $0.02 . More news on: Brainsway Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-16 23:06:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BURLINGTON, Mass. and JERUSALEM, June 17, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced its broad market...